Bio-Techne Corporation (TECH)

Bio-Techne Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	140.67	151.79	180.57	172.57	199.09	146.63
Short-Term Investments	-	1.07	23.74	74.46	32.46	124.27
Cash & Short-Term Investments	140.67	152.86	204.31	247.03	231.55	270.89
Cash Growth	-3.19%	-25.18%	-17.29%	6.68%	-14.52%	63.16%
Receivables	237.14	241.39	218.47	194.55	145.39	122.53
Inventory	191.08	179.73	171.64	141.12	116.75	103.15
Other Current Assets	58.35	43.43	27.07	22.86	16.92	24.34
Total Current Assets	627.24	617.42	621.48	605.56	510.61	520.92
Property, Plant & Equipment	335.72	342.44	324.53	288.8	281.74	248.29
Long-Term Investments	254.52	252.15	272.71	36.03	0.28	-
Goodwill	968.61	972.66	872.74	822.1	843.07	728.31
Other Intangible Assets	443.7	507.08	534.65	531.52	615.97	516.55
Other Long-Term Assets	14.47	12.12	12.59	10.8	11.3	13.52
Total Assets	2,644	2,704	2,639	2,295	2,263	2,028
Accounts Payable	31.64	37.97	25.68	33.87	29.38	23.09
Accrued Expenses	85.8	74.7	51.63	79.84	66.58	40.18
Current Portion of Long-Term Debt	-	-	-	12.98	13.28	12.5
Current Portion of Leases	14.05	12.92	11.2	11.93	11.6	9.54
Current Income Taxes Payable	3.63	3.71	12.02	13.24	5.34	2.38
Current Unearned Revenue	32.27	27.93	23.07	23.41	19	13.05
Other Current Liabilities	1.81	2.15	4.91	0.77	7.12	5.94
Total Current Liabilities	169.2	159.38	128.51	176.02	152.28	106.67
Long-Term Debt	330	319	350	243.41	336.43	361.57
Long-Term Leases	79.45	87.62	93.77	58.13	67.63	67.25
Long-Term Unearned Revenue	3.33	2.27	1.53	2.09	1.01	1.15
Long-Term Deferred Tax Liabilities	31.92	55.86	88.98	98.99	93.13	101.09
Other Long-Term Liabilities	12.33	10.89	9.39	15.15	41.26	8.67
Total Liabilities	626.23	635.02	672.18	593.79	691.72	646.4
Common Stock	1.57	1.58	1.58	1.57	0.39	0.39
Additional Paid-In Capital	902.12	820.34	721.54	652.47	534.41	420.54
Retained Earnings	1,196	1,325	1,309	1,123	1,085	1,057
Comprehensive Income & Other	-82.05	-78.32	-66.06	-75.2	-57.29	-97.2
Total Common Equity	2,018	2,069	1,967	1,702	1,563	1,381
Minority Interest	-	-	-	-0.76	8.26	-
Shareholders' Equity	2,018	2,069	1,967	1,701	1,571	1,381
Total Liabilities & Equity	2,644	2,704	2,639	2,295	2,263	2,028
Total Debt	423.5	419.54	454.97	326.45	428.93	450.86
Net Cash (Debt)	-282.83	-266.68	-250.66	-79.42	-197.38	-179.96
Net Cash Per Share	-1.76	-1.66	-1.55	-0.48	-1.22	-1.14
Filing Date Shares Outstanding	156.77	158.6	158.17	156.85	156.32	154.2
Total Common Shares Outstanding	156.76	158.22	157.64	156.64	155.82	153.81
Working Capital	458.04	458.04	492.97	429.54	358.32	414.25
Book Value Per Share	12.87	13.08	12.47	10.86	10.03	8.98
Tangible Book Value	605.71	589.11	559.13	348.15	103.94	136.34
Tangible Book Value Per Share	3.86	3.72	3.55	2.22	0.67	0.89
Land	8.11	8.15	9.1	8.57	8.61	8.52
Buildings	249.9	243.86	245.3	229.55	190.66	184.43
Machinery	240.95	215.95	190.02	174.81	149.41	153.7
Construction In Progress	31.82	39.75	15.49	21.73	49.07	-

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q